Infection and Immunity, April 2000, p. 2237-2244, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Unité de Biologie des Interactions Cellulaires, CNRS URA 1960,1 Unité de Biologie Moléculaire du Gène,3 and Unité de Histopathologie,4 Institut Pasteur, 75724 Paris Cedex 15, France, and Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 722022
Received 8 July 1999/Returned for modification 16 August 1999/Accepted 13 December 1999
| |
ABSTRACT |
|---|
|
|
|---|
The pathology observed during Chlamydia infection is
due initially to localized tissue damage caused by the infection
itself, followed by deleterious host inflammatory responses that lead to permanent scarring. We have recently reported that the infection by
Chlamydia in vitro results in apoptosis of epithelial cells and macrophages and that infected monocytes secrete the proinflammatory cytokine interleukin-1
. At the same time, proinflammatory cytokines such as tumor necrosis factor alpha (TNF-
) can also trigger
apoptosis of susceptible cells. To study the possible relationship
between Chlamydia trachomatis infection and apoptosis in
vivo, we used the terminal deoxynucleotidyltransferase-mediated dUTP
nick end labeling technique to determine whether infection may cause
apoptosis in the genital tract of mice and, conversely, whether
cytokines produced during the inflammatory response may modulate the
level of apoptosis. Our results demonstrate that infected cells in the endocervix at day 2 or 7 after infection are sometimes apoptotic, although there was not a statistically significant change in the number
of apoptotic cells in the endocervix. However, large clumps of
apoptotic infected cells were observed in the lumen, suggesting that
apoptotic cells may be shed from the endocervix. Moreover, there was a
large increase in the number of apoptotic cells in the uterine horns
and oviducts after 2 or 7 days of infection, which was accompanied by
obvious signs of upper tract pathology. Interestingly, depletion of
TNF-
led to a decrease in the level of apoptosis in the uterine
horns and oviducts of animals infected for 7 days, suggesting that the
inflammatory cytokines may exert part of their pathological effect via
apoptosis in infected tissues.
| |
INTRODUCTION |
|---|
|
|
|---|
Apoptosis is a key phenomenon in the regulation of cell population size and cell life span (18, 52). This process of cell death plays an important role in normal tissue homeostasis and in certain pathological conditions, including cancer. A growing number of studies over the last few years have shown that intracellular microbes can also modulate apoptosis of the host cell, either inhibiting or promoting cell death, and it has been proposed that the persistence and pathogenesis of several pathogenic microbes may be related to their ability to dysregulate apoptosis (2).
Although microbe-induced apoptosis has been extensively characterized for viral infections (2, 6, 47), apoptosis has also been observed during infections in vivo by bacteria or protozoan parasites, such as for Escherichia coli, Yersinia pseudotuberculosis, Trypanosoma cruzi, Shigella flexneri, Bordetella pertussis, Salmonella enterica serovar Typhimurium, and Toxoplasma gondii (13, 21, 26, 27, 34, 40, 59). Apoptosis due to infection by these pathogens may allow the pathogens to exit from infected cells, eliminate potentially dangerous phagocytic cells, and/or evade the host immune response or stimulate inflammatory responses (2, 5, 28, 30, 59). We recently reported that Chlamydia psittaci induces apoptosis in infected epithelial cells and macrophages in vitro (33), although we did not evaluate whether the infection has any effect on host cell viability in vivo.
In humans, the most common consequence of chlamydial genital infection is salpingitis, which can lead to tubal obstruction and infertility (4). In controlled studies in guinea pigs and mice (3, 9, 38), bacteria are initially detected in the cervical epithelium, but the pathology ascends in most animals to the endometrium and the oviducts within 7 to 9 days after intravaginal inoculation, culminating often in infertility. Most of the damage attributable to Chlamydia is due not to the infection itself but to the inflammation and fibrosis that follow the infection (4).
Polymorphonuclear leukocytes are typically observed in the cervix as
early as 2 days after infection, and acute inflammation in the uterine
horns and oviducts follows within 5 to 7 days after infection
(4). A number of inflammatory mediators are present during
infection, and these could contribute to tissue damage and fibrosis.
Two predominant cytokines usually produced during inflammation are
interleukin-1 (IL-1) and tumor necrosis factor (TNF-
), which
activate polymorphonuclear leukocytes and contribute to fibrosis due to
enhanced production of prostaglandins and collagen and increased
expression of integrin, as well as secretion of IL-6, IL-8, and
transforming growth factor
(32, 51, 58). TNF-
has in
fact been detected in the fallopian tubes of women infected with
Chlamydia (48) and in secretions from
Chlamydia-infected mice and guinea pigs (7, 8,
54). Results based on studies using mice that display mouse
strain-dependent variations in the pathological outcome of
Chlamydia genital infection and correspondingly different
levels of TNF-
production have suggested that while TNF-
and
other inflammatory cytokines may aid in eradicating Chlamydia infection, they may also promote long-term tissue
damage (7).
The preferential target tissue of sexually transmitted chlamydial
infections in females is the columnar epithelium of the cervix (4,
29), but monocytes and macrophages can also be infected
(23) and may aid in disseminating the infection by certain
serovars of Chlamydia. As macrophages undergoing apoptosis secrete IL-1 (15), it is conceivable that apoptosis of these cells during Chlamydia infection may contribute to the
inflammatory response. Conversely, cytokines such as TNF-
are able
to induce apoptosis of some target cells (12), suggesting
that the inflammation following Chlamydia infection may also
directly trigger apoptosis.
We have therefore investigated apoptosis in the genital tract of mice
using the terminal deoxynucleotidyltransferase-mediated dUTP nick end
labeling (TUNEL) method, which reveals early DNA breaks during
apoptosis (42), allowing identification of apoptotic cells
that may have evaded detection by conventional histological techniques.
The potential effect of the inflammatory response on apoptosis was
evaluated by measuring apoptosis in the uterine horns and oviducts in
infected mice whose TNF-
levels had been depleted with antibodies.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cells and animals. HeLa 299 cells, McCoy cells, and L cells (American Type Culture Collection, Manassas, Va.) were maintained in a humidified incubator at 37°C with 5% CO2 in Dulbecco modified Eagle medium (Life Technologies, Inc., Rockville, Md.) supplemented with 10% heat-inactivated fetal calf serum and 2 mM L-glutamine. The Chlamydia species used here, the mouse pneumonitis strain (MoPn) of C. trachomatis (3, 45), was obtained from Roger Rank (University of Arkansas) and was grown in L cells and purified by Renografin as previously described for C. psittaci (14). The quantity of bacterial inclusion-forming units (IFU) was determined by incubating the chlamydiae with McCoy cells for 1 day and revealing the presence of bacteria by immunofluorescence with fluorescein isothiocyanate-labeled anti-Chlamydia antibodies (lipopolysaccharide [LPS]-specific monoclonal antibody clone C4; Argene, Varilhes, France). Four-week-old female C57BL/6 mice were purchased from IFFA CREDO (L'Arbresle, France).
Infections. For infections in vitro, HeLa 229 cells growing at about 70% confluence on tissue culture flasks (Costar) were infected with a multiplicity of infection (MOI) of 6.6 as previously described for C. psittaci (32) and incubated during the indicated times at 37°C.
For infections in vivo, mice first received 2.5 mg of medroxyprogesterone acetate (Sigma Chemical Co., St. Louis, Mo.; or Upjohn, Kalamazoo, Mich.) subcutaneously at 3 and 10 days before infection (7). Infection was initiated by placing 50 µl of SPG buffer (250 mM sucrose-10 mM sodium phosphate-5 mM L-glutamic acid [pH 7.2]), containing 50 µg of gentamicin per ml and 106 IFU of C. trachomatis MoPn into the vaginal vault of the mice, corresponding to a 50% infectious dose of 4 × 102 (unpublished observations). Uninfected control mice were inoculated intravaginally with the same volume of SPG buffer and gentamicin. For these experiments, two uninfected mice and six infected mice were sacrificed after 2 days, and two uninfected mice and seven infected mice were sacrificed after 7 days. For TNF-
depletion experiments, 4- to 6-week-old C57BL/6 mice were
purchased from Jackson Laboratories (West Grove, Pa.). To study the
effect of TNF-
depletion, the mice received 2.5 mg of
medroxyprogesterone acetate subcutaneously 7 days before vaginal
infection and were injected intravaginally with 150 µg of polyclonal
anti-mouse TNF-
antibodies (Endogen, Woburn, Mass.) twice a day on
days 0, 2, 4, and 6 of infection with 107 IFU of C. trachomatis MoPn in SPG and 50 µg of gentamicin per ml (50%
infectious dose of 4 × 103). Control mice were
injected intravaginally with 150 µg of normal rabbit immunoglobulin G (Endogen).
It should be noted that previous studies have used 107 IFU
to infect mice (20, 50). In our case, we observed that
106 and 107 IFU gave similar apoptosis and
TNF-
depletion results.
FACS analysis of apoptosis. Quantitative measurement of apoptosis was performed by cytofluorimetry of detergent-permeabilized propidium iodide-stained cells as described elsewhere (10). Both adherent cells and cells in the supernatant were collected for analysis. The cells were transferred into 12- by 75-mm FALCON 2052 fluorescence-activated cell sorting (FACS) tubes (Becton Dickinson, San Jose, Calif.). Data from 10,000 HeLa cells were collected on a FACScan flow cytometer (Becton Dickinson) with an argon ion laser tuned to 488 nm. Apoptosis was measured in the FL2 range.
DNA fragmentation assay. Infected or uninfected HeLa cells were washed with phosphate-buffered saline and centrifuged (1,200 rpm for 5 min), and the pellet was incubated for 1 h at 37°C with 2 ml of lysis buffer containing 0.6% sodium dodecyl sulfate, 10 mM EDTA, 10 mM Tris, and 20 µg of RNase A per ml. Two hundred microliters of 5 M NaCl was then added, and this solution was incubated for 40 min on ice and finally centrifuged for 30 min at 13,000 × g. The DNA was extracted from the supernatant with phenol-chloroform-isoamyl alcohol (25:24:1), precipitated with absolute ethanol, and treated with RNase A (40 µg/ml) at 37°C for 30 min. Finally, the amount of DNA from each sample was normalized by measuring the optical density at 260 nm, and the DNA was loaded onto a 1.8% agarose gel containing 0.4 µg of ethidium bromide per ml.
Histological procedures. Mice were sacrificed 2 and 7 days after vaginal infection. The entire genital tract was removed, fixed in 4% paraformaldehyde, and embedded in 37°C paraffin. Longitudinal 4-µm sections were cut, stained with hematoxylin and eosin (Shandon) or with an unconjugated anti-C. trachomatis monoclonal antibody (1:100 dilution; Biogene Sis), and incubated with a peroxidase-conjugated anti-mouse immunoglobulin antibody (Dako). Infected cells were revealed in red with the AEC dimethyl formamide substrate (Sigma) on eosin-counterstained tissue.
To identify apoptotic cells, the cuts were double stained with a murine anti-MoPn immune serum (1:500 dilution) obtained from infected mice (7) and the TUNEL method, using a cell death detection kit from Boehringer Mannheim (Meylan, France) as instructed by the manufacturer. The infected cells were revealed with the unconjugated anti-MoPn immune serum followed by incubation with trimethyl rhodamine isothiocyanate-conjugated rabbit anti-mouse immunoglobulins (DAKO SA, Trappes, France), and the apoptotic cells appeared in green due to the fluorescein-labeled dUTP. Samples were examined with a Zeiss Axiophot microscope attached to a cooled charge-coupled device camera (Photometrics), and images were acquired and analyzed with the IPLab spectrum program (Signal Analytics Corporation, Vienna, Va.).Quantification of apoptotic cells in vivo. The IPLab spectrum program was used to quantify the relative number of apoptotic cells in each tissue. To distinguish fluorescently positive cells from nonapoptotic cells, a threshold of fluorescence intensity was defined using a sample that had been stained with the TUNEL kit without the terminal deoxynucleotidyltransferase enzyme. Under these conditions, the minimal threshold of fluorescence intensity that excludes the false-positive cells was defined. To identify the apoptotic cells in images, the IPLab spectrum program was used to add a green color to the cells with a fluorescence intensity under the threshold level (nonapoptotic cells) and a red color to the cells with a fluorescence intensity higher than the threshold level (apoptotic cells). The relative number of apoptotic cells per image was then counted, and 10 fields were analyzed per tissue.
| |
RESULTS |
|---|
|
|
|---|
Apoptosis of epithelial cells in vitro during infection with the
murine strain of C. trachomatis.
We have recently reported
that the guinea pig inclusion conjunctivitis (GPIC) serovar of C. psittaci induces apoptosis of epithelial cells, with apoptosis
being measurable after a 1-day infection (33). To determine
whether the murine strain of C. trachomatis, MoPn, shares
this property, we measured the time course of apoptosis of the
epithelial cell line, HeLa, by cytofluorimetry using iodide
propidium-stained, detergent-permeabilized cells as described in
Materials and Methods. We observed few apoptotic cells during short
infection times, but significant levels were detected after a 42-h
infection, at which point release of MoPn elementary bodies begins to
occur (not shown), and most of the cells were apoptotic after a 2-day
infection (Fig. 1A). This time course is
reminiscent of the apoptosis previously observed during infection in
vitro with C. psittaci (33), although the
kinetics were slightly slower for MoPn-induced apoptosis and the MOI
required for MoPn (6.6) was higher than that required for GPIC (1.0).
|
Apoptosis in the murine genital tract during infection with C. trachomatis. To establish whether C. trachomatis may also induce apoptosis in vivo, we used the murine model of C. trachomatis MoPn genital infection (3). After injection of progesterone to synchronize the estrus cycle, female C57BL/6 mice were infected intravaginally with chlamydiae. Tissues for histological analysis were obtained by sacrificing mice after 2 or 7 days of infection. The entire genital tract was excised en bloc, fixed in paraformaldehyde, and processed for histology or TUNEL as described in Materials and Methods. The cervix, uterine horn, and oviduct were then assessed separately for the presence of inflammation and apoptosis.
Two days after infection, the infected cervix had visibly damaged cells, some of which were condensed, and there was a low level of infiltration of inflammatory cells (Fig. 2C). Most of the damaged cells were present in the stratified squamous epithelium of the vagina. The inflammatory response became significantly enhanced after 7 days of infection, with a heavy infiltration of mono- and polymorphonuclear cells in the uterine mucosa (Fig. 2E). As a control, there was no inflammation nor chlamydial staining in uninfected mice (Fig. 2A and data not shown).
|
|
|
Role of TNF-
in modulating apoptosis in the uterine horns and
oviducts.
In C57BL/6 mice, TNF-
has been detected in genital
tract secretions of animals during the first week of infection with
C. trachomatis MoPn (7, 8). TNF-
is also known
to trigger apoptosis of a diverse range of cells in vitro
(12). We therefore depleted TNF-
levels in vivo by
injecting mice with a polyclonal anti-mouse TNF-
before and during
infection with C. trachomatis, as described in Materials and Methods.
levels in endocervical secretions from mice injected with
anti-TNF-
antibodies, determined by enzyme-linked immunosorbent assay (ELISA), were significantly lower than in controls (P < 0.001 by two-way analysis of variance). The Tukey test revealed significant decreases on days 4 through 7 (not shown). Thus, TNF-
levels on day 5 were 1,070 ± 470 pg/ml in controls and 270 ± 22 pg/ml in the antibody-treated group. On day 7, TNF-
levels
were 780 ± 450 pg/ml in controls and 100 ± 60 pg/ml in the
antibody-treated group (Fig. 5).
Treatment with anti-TNF-
antibodies had no effect on levels of gamma
interferon and IL-1
(not shown).
|
levels were
diminished by administration of anti-TNF-
antibodies, suggesting
that TNF-
produced during Chlamydia infection contributes to apoptosis in the upper genital tract.
| |
DISCUSSION |
|---|
|
|
|---|
We have previously reported that epithelial cells and macrophages die through apoptosis during infection with C. psittaci in vitro (33). To determine whether apoptosis may be induced by infection in vivo, we used the TUNEL technique to quantify the number of apoptotic cells in the genital tract of female mice during infection with C. trachomatis, having verified first that C. trachomatis infection leads to apoptosis in vitro with similar characteristics as observed during C. psittaci-induced apoptosis.
We observed a large increase in the number of apoptotic cells in the uterine horns and oviducts of mice infected with C. trachomatis, and the apoptotic cells were present in both the epithelium and submucosa. However, the results were ambiguous in the case of the lower genital tract, which already had a large number of spontaneously apoptotic cells in uninfected mice. Infected cells that were also apoptotic were in fact observed in the endocervix of infected mice, but we did not observe a quantitative difference in the levels of apoptosis between infected and uninfected mice. Clusters of apoptotic infected cells were found in the lumen of the vagina after a 2-day infection, and it is thus possible that the apoptotic cells may be shed from the surface epithelial cells, as has been shown for shedding of apoptotic cells during menstruation (44). In this respect, shedding of apoptotic cells may be a general phenomenon provoked by infection with different Chlamydia species and strains, since it had previously been reported that dying infected cells with a condensed nucleus are released from the cervical epithelium of guinea pigs infected with the GPIC strain of C. psittaci (43). Alternatively, or simultaneously, since apoptotic cells in vivo are normally recognized and degraded by neighboring phagocytic cells (36), it is conceivable that the infected cells undergoing apoptosis may be rapidly cleared from the tissue by phagocytes.
During apoptosis of epithelial cells in vitro, the majority of the
apoptotic cells were infected, although many uninfected apoptotic cells
were also observed (33). We had therefore proposed that
chlamydiae may induce apoptosis directly through infection, but that
locally produced cytokines secreted during initial phases of the
infection may also cause apoptosis of uninfected cells. Several
cytokines are in fact secreted by cells infected by
Chlamydia both in vitro and in vivo. Infection of an
epithelial cell line causes release of the proinflammatory cytokine
IL-1
(39), and incubation of dendritic cells and
monocytes with chlamydiae in vitro results in secretion of TNF-
and
IL-1
, respectively (31, 33). In vivo, an acute
inflammatory response is the dominant host response in the early stages
of the infection and is observed in the endometrium and oviducts within
a few days of infection (4). In mice, TNF-
has been
detected in the genital tract secretions of animals inoculated with
C. trachomatis MoPn. High levels were measured within 2 days
after intravaginal inoculation, peaked at 6 days, and decreased after a
week (7). It had been proposed that TNF-
may aid the host
to eradicate the chlamydiae, thus preventing infection of the oviduct
(7). Hence, TNF-
, in conjunction with gamma interferon,
transforming growth factor
, and IL-1 (25, 37, 55, 56),
may be a factor responsible for the inflammatory response and
consequent fibrosis.
While TNF-
is a pleiotropic cytokine that is cytocidal for tumor
cells, it also has effects on untransformed cells (1, 24, 35,
41), and it has been proposed that TNF-
may serve as the local
signal contributing to the processes of shedding and bleeding in humans
during menstruation (46). Favoring the likelihood that
TNF-
could also trigger apoptosis during Chlamydia infection, we have observed a large increase in the number of apoptotic
cells in the uterine horns and oviducts, which was partially inhibited
by depletion with antibodies against TNF-
. In addition, the number
of apoptotic cells in the upper tract of TNF-
-depleted mice that had
been infected for 7 days is close to the number observed in untreated
mice that had been infected for 2 days, further reinforcing the
possibility that the increased level of apoptosis in untreated mice
infected for 7 days may be due to proinflammatory cytokines, since the
inflammatory response in oviducts of C57 mice infected with C. trachomatis MoPn does not begin until at least 3 days of infection
(7).
It has previously been reported that Chlamydia infections in vitro induce apoptosis toward the end of the infection cycle (reference 33 and this work) and protect infected cells against apoptosis due to external ligands (11). During infections in vivo, most of the cells dying as a result of the inflammatory response in the upper genital tract at day 7 do not appear to be infected and thus should not be protected. Alternatively, infected cells in vivo may be protected only partially, compared to the results previously reported with cell lines in vitro.
The observation that TNF-
can modulate apoptosis during infection
with C. trachomatis is reminiscent of the role played by this cytokine during infections with Mycobacterium
tuberculosis, which leads to apoptosis of alveolar macrophages in
vivo. Addition of TNF-
increases the cytotoxicity, while treatment
of infected macrophages with pentoxifylline or anti-TNF-
antibodies
increase host cell survival (19). Extensive apoptosis was
also detected within caseating granulomas from lung tissue samples from
clinical tuberculosis cases (19), suggesting that
TNF-
-dependent apoptosis during M. tuberculosis infection
could contribute to the pathology in a clinical setting.
Part of the TNF-
production during bacterial infections could result
from LPS stimulation of host immune cells. Thus, in vivo administration
of Porphyromonas gingivalis LPS induced apoptosis in the
spleen, lymph nodes, and thymus (17). Serum TNF-
levels were higher than in untreated controls, and recombinant TNF-
also
caused apoptosis (17), as was previously shown for LPS from
Escherichia coli. Although it has been reported that
Chlamydia LPS or whole chlamydiae are weak inducers of
TNF-
secretion from isolated whole blood cells (16), it
is possible that a small population of effector cells in the genital
tract mucosa, such as dendritic cells (31), could be
responsible for the high levels of TNF-
observed during
Chlamydia infection in vivo (7, 8).
In conclusion, we propose that Chlamydia-induced release of
IL-1 and TNF-
, possibly acting in concert with other inflammatory cytokines, could lead to apoptosis of directly infected and/or neighboring cells. Finally, as macrophages and monocytes undergoing apoptosis also release IL-1 (15), the cells secreting the
proinflammatory cytokines, as well as the cells undergoing
Chlamydia-induced apoptosis in vivo, need to be identified
in order to evaluate their contribution to the pathology of
Chlamydia infections.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Roger Rank (University of Arkansas) for helpful suggestions during the course of the work and for constructive criticisms of the manuscript and to Huot Khun for assistance in preparing histological sections.
This investigation was financed by funds from the Institut Pasteur, CNRS, and Ligue Nationale Contre le Cancer (Comité de Paris) for purchase of the CCD camera and by NIH grant R01 AI43337-01A1.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité de Biologie des Interactions Cellulaires, CNRS URA 1960, Institut Pasteur, 75724 Paris Cedex 15, France. Phone: (33) 1 40 61 30 64. Fax: (33) 1 40 61 32 38. E-mail: ojcius{at}pasteur.fr.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abreu-Martin, M. T.,
A. Vidrich,
D. H. Lynch, and S. R. Targan.
1995.
Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF- and ligation of Fas antigen.
J. Immunol.
155:4147-4154[Abstract].
|
| 2. | Ameisen, J. C., J. Estaquier, and T. Idziorek. 1994. From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol. Rev. 142:9-51[CrossRef][Medline]. |
| 3. | Barron, A. L., H. J. White, R. G. Rank, B. L. Soloff, and E. B. Moses. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66[Medline]. |
| 4. | Bavoil, P. M., R.-C. Hsia, and R. G. Rank. 1996. Prospects for a vaccine against Chlamydia genital disease. I. Microbiology and pathogenesis. Bull. Inst. Pasteur 94:5-54[CrossRef]. |
| 5. | Chinnaiyan, A. M., C. Woffendin, V. M. Dixit, and G. J. Nabel. 1997. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication. Nat. Med. 3:333-337[CrossRef][Medline]. |
| 6. | Collins, M. 1995. Potential roles of apoptosis in viral pathogenesis. Am. J. Respir. Crit. Care Med. 152:S20-S24. |
| 7. | Darville, T., C. W. Andrews, K. K. Laffoon, W. Shymasani, L. R. Kishen, and R. G. Rank. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital infection is associated with differences in host response. Infect. Immun. 65:3065-3073[Abstract]. |
| 8. | Darville, T., K. K. Laffoon, L. R. Kishen, and R. G. Rank. 1995. Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect. Immun. 63:4675-4681[Abstract]. |
| 9. |
de la Maza, L. M.,
S. Pal,
A. Khamesipour, and E. M. Peterson.
1994.
Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.
Infect. Immun.
62:2094-2097 |
| 10. | Douglas, R. S., A. D. Tarshis, C. H. Pletcher, P. C. Nowell, and J. S. Moore. 1995. A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes. J. Immunol. Methods 188:219-228[CrossRef][Medline]. |
| 11. |
Fan, T.,
H. Lu,
H. Hu,
L. Shi,
G. A. McClarty,
D. M. Nance,
A. H. Greenberg, and G. Zhong.
1998.
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation.
J. Exp. Med.
187:487-496 |
| 12. | Golstein, P., D. M. Ojcius, and J. D. Young. 1991. Cell death mechanisms and the immune system. Immunol. Rev. 121:29-65[CrossRef][Medline]. |
| 13. |
Gueirard, P.,
A. Druilhe,
M. Pretolani, and N. Guiso.
1998.
Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo.
Infect. Immun.
66:1718-1725 |
| 14. | Gutiérrez-Martin, C. B., D. M. Ojcius, R.-C. Hsia, R. Hellio, P. M. Bavoil, and A. Dautry-Varsat. 1997. Heparin-mediated inhibition of Chlamydia psittaci adherence to HeLa cells. Microb. Pathog. 22:47-57[CrossRef][Medline]. |
| 15. |
Hogquist, K. A.,
M. A. Nett,
E. R. Unanue, and D. D. Chaplin.
1991.
Interleukin 1 is processed and released during apoptosis.
Proc. Natl. Acad. Sci. USA
88:8485-8489 |
| 16. | Ingalls, R. R., P. A. Rice, N. Qureshi, K. Takayama, J. S. Lin, and D. T. Golenbock. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63:3125-3130[Abstract]. |
| 17. | Isogai, E., H. Isogal, K. Kimura, N. Fujii, S. Takagi, K. Hirose, and M. Hayashi. 1996. In vivo induction of apoptosis and immune responses in mice by administration of lipopolysaccharide from Porphyromonas gingivalis. Infect. Immun. 64:1461-1466[Abstract]. |
| 18. | Jacobson, M. D., M. Weil, and M. C. Raff. 1997. Programmed cell death in animal development. Cell 88:347-354[CrossRef][Medline]. |
| 19. | Keane, J., M. K. Balcewicz-Sablinska, H. G. Remold, G. L. Chupp, B. B. Meek, M. J. Fenton, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298-304[Abstract]. |
| 20. | Kelly, K. A., E. A. Robinson, and R. G. Rank. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect. Immun. 64:4976-4983[Abstract]. |
| 21. |
Khan, I. A.,
T. Matsuura, and L. H. Kasper.
1996.
Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.
Int. Immunol.
8:887-896 |
| 22. | Klahr, S., and J. J. Morrissey. 1998. The role of growth factors, cytokines, and vasocative compounds in obstructive nephropathy. Semin. Nephrol. 18:622-632[Medline]. |
| 23. | La Verda, D., and G. I. Byrne. 1994. Interactions between macrophages and chlamydiae. Immunol. Ser. 60:381-399[Medline]. |
| 24. | Leist, M., F. Gantner, I. Bohlinger, G. Tiegs, P. G. Germann, and A. Wendel. 1995. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1220-1234[Abstract]. |
| 25. |
Magee, D. M.,
J. G. Smith,
C. A. Bleicker,
C. J. Carter,
L. F. Bonewald,
J. Schachter, and D. M. Williams.
1992.
Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.
Infect. Immun.
60:1217-1220 |
| 26. | McOrist, S., L. Roberts, S. Jasni, A. C. Rowland, G. H. Lawson, C. J. Gebhart, and B. Bosworth. 1996. Developed and resolving lesions in porcine proliferative enteropathy: possible pathogenetic mechanisms. J. Comp. Pathol. 115:35-45[CrossRef][Medline]. |
| 27. |
Monack, D. M.,
J. Mecsas,
D. Bouley, and S. Falkow.
1998.
Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.
J. Exp. Med.
188:2127-2137 |
| 28. |
Monack, D. M.,
B. Raupach,
A. E. Hromockyj, and S. Falkow.
1996.
Salmonella typhimurium invasion induces apoptosis in infected macrophages.
Proc. Natl. Acad. Sci. USA
93:9833-9838 |
| 29. |
Moulder, J. W.
1991.
Interaction of chlamydiae and host cells in vitro.
Microbiol. Rev.
55:143-190 |
| 30. | Muller, A., J. Hacker, and B. C. Brand. 1996. Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection. Infect. Immun. 64:4900-4906[Abstract]. |
| 31. |
Ojcius, D. M.,
Y. Bravo de Alda,
J. M. Kanellopoulos,
R. A. Hawkins,
K. A. Kelly,
R. G. Rank, and A. Dautry-Varsat.
1998.
Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells.
J. Immunol.
160:1297-1303 |
| 32. |
Ojcius, D. M.,
H. Degani,
J. Mispelter, and A. Dautry-Varsat.
1998.
Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells.
J. Biol. Chem.
273:7052-7058 |
| 33. |
Ojcius, D. M.,
P. Souque,
J.-L. Perfettini, and A. Dautry-Varsat.
1998.
Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci.
J. Immunol.
161:4220-4226 |
| 34. |
Pai, C. H.,
J. K. Kelly, and G. L. Meyers.
1986.
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli.
Infect. Immun.
51:16-23 |
| 35. | Peralta Soler, A., J. M. Mullin, K. A. Knudsen, and C. W. Marano. 1996. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Physiol. 270:869-879. |
| 36. | Platt, N., R. P. da Silva, and S. Gordon. 1998. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol. 8:365-372[CrossRef][Medline]. |
| 37. |
Rank, R. G.,
K. H. Ramsey,
E. A. Pack, and D. M. Williams.
1992.
Effect of gamma interferon on resolution of murine chlamydial genital infection.
Infect. Immun.
60:4427-4429 |
| 38. | Rank, R. G., and M. M. Sanders. 1992. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140:927-936[Abstract]. |
| 39. | Rasmussen, S. J., L. Eckmann, A. J. Quayle, L. Shen, Y. X. Zhang, D. J. Anderson, J. Fierer, R. S. Stephens, and M. F. Kagnoff. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Investig. 99:77-87[Medline]. |
| 40. |
Richter-Dahlfors, A.,
A. M. J. Buchan, and B. B. Finlay.
1997.
Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo.
J. Exp. Med.
186:569-580 |
| 41. | Robaye, B., R. Mosselmans, W. Fiers, J. E. Dumont, and P. Galand. 1991. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:447-453[Abstract]. |
| 42. | Sgonc, R., and G. Wick. 1994. Methods for the detection of apoptosis. Int. Arch. Allergy Immunol. 105:327-332[Medline]. |
| 43. | Soloff, B. L., R. G. Rank, and A. L. Barron. 1985. Electron microscopic observations concerning the in vivo uptake and release of the agent of guinea-pig inclusion conjunctivitis (Chlamydia psittaci) in guinea-pig exocervix. J. Comp. Pathol. 95:335-344[CrossRef][Medline]. |
| 44. | Spencer, S. J., N. A. Cataldo, and R. B. Jaffe. 1996. Apoptosis in the human female reproductive tract. Obstet. Gynecol. Surv. 51:314-323[CrossRef][Medline]. |
| 45. | Stephenson, E. H., and J. Storz. 1975. Protein profiles of dense-centered forms of five chlamydial strains of animal origin. Am. J. Vet. Res. 36:881-887[Medline]. |
| 46. |
Tabibzadeh, S.
1996.
The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling.
Mol. Hum. Reprod.
2:77-92 |
| 47. |
Thompson, C. B.
1995.
Apoptosis in the pathogenesis and treatment of disease.
Science
267:1456-1462 |
| 48. | Toth, M., J. Jeremias, W. J. Ledger, and S. S. Witkin. 1992. In vivo tumor necrosis factor production in women with salpingitis. Surg. Gynecol. Obstet. 174:359-362[Medline]. |
| 49. | Tribby, I. I., R. R. Friis, and J. W. Moulder. 1973. Effect of chloramphenicol, rifampicin, and nalidixic acid on Chlamydia psittaci growing in L cells. J. Infect. Dis. 127:155-163[Medline]. |
| 50. |
Tseng, C.-T., and R. Rank.
1998.
Role of NK cells in early host response to chlamydial genital infection.
Infect. Immun.
66:5867-5875 |
| 51. | van den Berg, W. B. 1997. Lessons for joint destruction from animal models. Curr. Opin. Rheumatol. 9:221-228[CrossRef][Medline]. |
| 52. | Vaux, D. L., and S. J. Korsmeyer. 1999. Cell death in development. Cell 96:245-254[CrossRef][Medline]. |
| 53. | Vining, L. C., and C. Stuttard. 1995. Chloramphenicol. Bio/Technology 28:505-530[Medline]. |
| 54. |
Williams, D. M.,
L. F. Bonewald,
G. D. Roodman,
G. I. Byrne,
D. M. Magee, and J. Schachter.
1989.
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.
Infect. Immun.
57:1351-1355 |
| 55. | Williams, D. M., B. G. Grubbs, S. Park-Snyder, R. G. Rank, and L. F. Bonewald. 1996. Activation of latent transforming growth factor beta during Chlamydia trachomatis-induced murine pneumonia. Res. Microbiol. 147:251-262[Medline]. |
| 56. |
Williams, D. M.,
D. M. Magee,
L. F. Bonewald,
J. G. Smith,
C. A. Bleicker,
G. I. Byrne, and J. Schachter.
1990.
A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.
Infect. Immun.
58:1572-1576 |
| 57. | Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306[Medline]. |
| 58. | Zhang, K., and S. H. Phan. 1996. Cytokines and pulmonary fibrosis. Biol. Signals 5:232-239[Medline]. |
| 59. | Zychlinsky, A., K. Thirumalai, J. Arondel, J. R. Cantey, A. O. Aliprantis, and P. J. Sansonetti. 1996. In vivo apoptosis in Shigella flexneri infections. Infect. Immun. 64:5357-5365[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|